about
C-abl oncogene 1, non-receptor tyrosine kinaseGrowth factor receptor bound protein 2Aquaporin 1LYN proto-oncogene, Src family tyrosine kinaseAquaporin 1Chimerin 1EPH receptor A4CRK proto-oncogene, adaptor proteinAnkyrin repeat and sterile alpha motif domain containing 1BAnkyrin repeat and sterile alpha motif domain containing 1ASRC proto-oncogene, non-receptor tyrosine kinaseCyclin dependent kinase 5 regulatory subunit 1NCK adaptor protein 1EPH receptor A7SHC adaptor protein 1Cyclin dependent kinase 5Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gammaSignal induced proliferation associated 1 like 1Ephrin A2Ephrin A1Ephrin A3Ephrin A4Ephrin B2Ephrin A5Ephrin B1Ephrin B3Cbl proto-oncogeneProtein tyrosine phosphatase non-receptor type 1Ankyrin repeat and SAM domain containing 1Ankyrin repeat and sterile alpha motif domain containing 1BCasitas B-lineage lymphomaCyclin-dependent kinase 5T-lymphoma invasion and metastasis-inducing protein 1Eph receptor A4Chimerin 1Ephrin A4Ephrin A5Ephrin A3Syndecan binding proteinEphrin B3
P680
Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activityThe EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent mannerIdentification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling functionStructural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificityCharacterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testisEphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis
P921
Q14874000-7225677F-CF2B-4EE9-AF73-31612466B416Q14905190-5FCED171-5382-40D9-9D28-6EB6813C25BEQ14905246-F038389A-876A-4105-B343-B1FE97CE5214Q15331919-6752D10E-B67F-4F1A-A7B8-D44DAE3CC35AQ2083074-46DDD5AB-76AF-49D5-9E38-E37331FBCE96Q21100737-AF8CFDDF-C2A6-4CA3-A5CF-7C89CC311229Q21101203-417CC7A8-1BFD-4D6F-8DDF-EF6BA9AA8F6EQ21104797-649F3041-33C3-4B53-8144-1768081347F3Q21108201-BDAFC443-D16C-4A1B-9598-7CF6722173D9Q21108203-40FBCAD4-8A40-421B-B3AC-DFDF04E420F2Q21109354-614F526D-9725-4F28-A146-CDFC34591D86Q21109701-CA83FAD5-1B25-4F8F-9EF4-67592D17EB58Q21113662-F8539BCB-2738-4AE4-A5CA-C2C87AE18375Q21114364-0D4F67F6-3946-4AF7-B81F-E5781EA3F011Q21116165-AD45AF4F-2C67-4345-BE20-0A84AD41FBB5Q21116933-F62F9806-A928-45B4-9D7F-CD5BC1A42B46Q21123236-5CEB549B-AE1F-453B-9BB5-3D432A2C59B7Q21136014-82001BF3-0B60-4B4F-A518-7CB046B6AB15Q21156330-5F770A93-0F72-4CB7-AF5A-F07AFED11DCBQ21156333-C7A0E03B-2BFF-4822-AE85-FD41D16E5E67Q21156333-D8AB3730-6F39-4CE7-8BF9-579D93F93A4EQ21156339-4AC3E572-AAF7-4D5E-AC4A-F9EB24D8040EQ21156339-74680BA3-8B70-4902-AD5D-D00DB63E21D6Q21156341-2BFE50ED-CC25-4934-B0C2-4381272563A8Q21156341-F4DC8ED3-1323-4CEB-B806-5726276B8554Q21156343-4EE1B99A-29CF-4532-9C5B-871A02DD73D8Q21156343-51941E5B-5CAA-4E6B-A585-0E58AF5FAA71Q21156348-67B19EF8-3A65-4900-8C7D-7517397F9B33Q21156348-8AABF9CC-57F1-46CC-A50D-43C8754336F9Q21156350-ABEA34DC-B81A-4502-A1DE-7D4A9A2AD980Q21156358-BBB27F97-8809-417D-9FAB-20F036661524Q21156358-C20EDC41-CA02-4A30-B17D-AAFBF3A5870DQ21171522-22BB1034-0C2F-4BEA-B824-115C0FFA0D10Q21171691-BA2DB40C-AC38-4D6C-A125-B46F1DC044EDQ21494841-5182F3BC-B468-43B4-AC2E-61614BBCB753Q21494849-D1F6B5F3-1A4B-4A63-8B74-D30E3F1B541DQ21494946-05FC7275-8BED-4CAB-A7C5-A7626FC4C23EQ21495012-4B950B19-020C-4094-8AE7-A30CA3EF25E6Q21495012-BF5C9E5A-A5C8-49F6-8779-CFAF407B060DQ21495013-C777C0EA-CD67-4990-85AE-89D156F6BB63
P680
description
Interacting selectively and non-covalently with an ephrin receptor.
@en
moleculaire functie
@nl
name
ephrin receptor binding
@en
pengikatan reseptor efrin
@id
type
label
ephrin receptor binding
@en
pengikatan reseptor efrin
@id
altLabel
Eph receptor binding
@en
GO:0046875
@en
prefLabel
ephrin receptor binding
@en
pengikatan reseptor efrin
@id
P279
P2888
P686
GO:0046875